XOMA Announces Closing of Depositary Shares Offering and Exercise of Underwriters’ Option
April 12, 2021 07:30 ET
|
XOMA Corporation
Raised aggregate gross proceeds of $40 million Depositary shares represent an interest in 8.375% Series B Cumulative Perpetual Preferred Stock EMERYVILLE, Calif., April 12, 2021 (GLOBE NEWSWIRE)...
XOMA Prices $35 Million Offering of Depositary Shares
April 06, 2021 19:02 ET
|
XOMA Corporation
EMERYVILLE, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the pricing of its underwritten registered public offering of...
XOMA Announces Offering of Depositary Shares and Series B Cumulative Perpetual Preferred Stock
April 05, 2021 16:05 ET
|
XOMA Corporation
EMERYVILLE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has commenced an underwritten registered public offering of...
XOMA to Present at the Cowen & Company Health Care Conference
March 02, 2016 13:30 ET
|
XOMA Corporation
BERKELEY, Calif., March 02, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today Paul Rubin, the Company’s...